Discours économique et évolution institutionnelle, les apports de J. R. Commons

John Roger Commons est, de manière quasi systématique, considéré comme l'un des pères fondateurs de l'ancien institutionnalisme américain. On souligne tout aussi couramment l'influence que la philosophie pragmatiste a pu avoir sur ses travaux, du moins en ce qui concerne son ouvrage de 1934. Plus rares sont les commentateurs soulignant le rôle qu'a le langage, a fortiori le langage de l'économiste, dans l'analyse qu'il fait de l'évolution institutionnelle. Notre but sera de souligner ce fait : pour Commons, dire c'est faire, dans la lignée de la linguistique performativiste, dire c'est agir sur l'évolution institutionnelle. Abstract : John Roger Commons is well known as one of the founders of old institutionnalism. It is current to emphazise his philosophical roots : the american pragmatism, at least in his masterpiece of 1934. On the other hand, it is less frequent to point out the important role that the langage, and a fortiori economics' langage, has in his understanding of institutional evolution. Our aim will be to spotlight this point : for Commons, we can do things with words, on the way of performativist linguistic, when we use words, we influence institutional evolution.

Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial.

BACKGROUND AND OBJECTIVES: The SBP values to be achieved by antihypertensive therapy in order to maximize reduction of cardiovascular outcomes are unknown; neither is it clear whether in patients with a previous cardiovascular event, the optimal values are lower than in the low-to-moderate risk hypertensive patients, or a more cautious blood pressure (BP) reduction should be obtained. Because of the uncertainty whether 'the lower the better' or the 'J-curve' hypothesis is correct, the European Society of Hypertension and the Chinese Hypertension League have promoted a randomized trial comparing antihypertensive treatment strategies aiming at three different SBP targets in hypertensive patients with a recent stroke or transient ischaemic attack. As the optimal level of low-density lipoprotein cholesterol (LDL-C) level is also unknown in these patients, LDL-C-lowering has been included in the design. PROTOCOL DESIGN: The European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment trial is a prospective multinational, randomized trial with a 3 × 2 factorial design comparing: three different SBP targets (1, <145-135; 2, <135-125; 3, <125 mmHg); two different LDL-C targets (target A, 2.8-1.8; target B, <1.8 mmol/l). The trial is to be conducted on 7500 patients aged at least 65 years (2500 in Europe, 5000 in China) with hypertension and a stroke or transient ischaemic attack 1-6 months before randomization. Antihypertensive and statin treatments will be initiated or modified using suitable registered agents chosen by the investigators, in order to maintain patients within the randomized SBP and LDL-C windows. All patients will be followed up every 3 months for BP and every 6 months for LDL-C. Ambulatory BP will be measured yearly. OUTCOMES: Primary outcome is time to stroke (fatal and non-fatal). Important secondary outcomes are: time to first major cardiovascular event; cognitive decline (Montreal Cognitive Assessment) and dementia. All major outcomes will be adjudicated by committees blind to randomized allocation. A Data and Safety Monitoring Board has open access to data and can recommend trial interruption for safety. SAMPLE SIZE CALCULATION: It has been calculated that 925 patients would reach the primary outcome after a mean 4-year follow-up, and this should provide at least 80% power to detect a 25% stroke difference between SBP targets and a 20% difference between LDL-C targets.

LSI-R Scores: Change Matters, Data Download, Iowa Department of Corrections, April 2009

Past studies have shown the LSI-R risk assessment tool to be accurate in assessing the risk level of Iowa offenders. A more recent study, conducted by the University of Cincinnati, showed that a reduction in the LSI-R score over time results in a lower risk that an Iowa offender will reoffend.

LSI-R Scores: Change Matters - Part II, Data Download, Iowa Department of Corrections

In the last issue of the Data Download, we discussed that overall, a 10% drop in LSI-R scores for our highest risk offenders was associated with a 6% reduction in recidivism. However, LSI-R score reductions for the lowest risk offenders don't substantially affect their already low recidivism rates. The issue contained charts that showed this held true for both probationers and parolees. The charts below show that change also matters for women offenders and African-American offenders.

LSI-R Scores: Change Matters - Part III, Data Download, Iowa Department of Corrections, June 2009

In this issue, we take a closer look at the individual risk factors measured by the LSI-R. There are several risk factors that the LSI-R assessment tool measures: Criminal History; Education/Employment; Financial; Family/Marital; Accommodations (Living Situation); Leisure/Recreation; Companions; Alcohol/Drug Problem; Emotional/Personal; and Attitudes/Orientation.

Paroxetine increases steady-state concentrations of (R)-methadone in CYP2D6 extensive but not poor metabolizers

Steady-state blood concentrations of (R)- methadone (i.e., the active form), (S)-methadone, and (R,S)-methadone were measured before and after introduction of paroxetine 20 mg/day during a mean period of 12 days in 10 addict patients in methadone maintenance treatment. Eight patients were genotyped as CYP2D6 homozygous extensive metabolizers (EMs) and two patients as poor metabolizers (PMs). Paroxetine significantly increased concentrations of both enantiomers of methadone in the whole group (mean increase for (R)-methadone +/- SD, 26 +/- 32%; range, -14% to +83%, p = 0.032; for (S)-methadone, 49 +/- 51%; range, -29% to +137%, p = 0.028; for (R,S)-methadone, 35 +/- 41%; range, -20% to +112%, p = 0.032) and in the group of eight EMs (mean increase, 32%, p = 0.036; 53%, p = 0.028; and 42%, p = 0.036, for (R)-methadone, (S)-methadone, and (R,S)-methadone, respectively). On the other hand, in the two PMs, (S)-methadone but not (R)-methadone concentrations were increased by paroxetine (mean increases of 36% and 3%, respectively). Paroxetine is a strong CYP2D6 inhibitor, and these results confirm previous studies showing an involvement of CYP2D6 in methadone metabolism with a stereoselectivity toward the (R)-enantiomer. Because paroxetine is a mild inhibitor of CYP1A2, CYP2C9, CYP2C19, and CYP3A4, increase of (S)-methadone concentrations in both EMs and PMs could be mediated by inhibition of any of these isozymes.

Front form and point form formulation in P.R.M. noninteractions theorems

The front form and the point form of dynamics are studied in the framework of predictive relativistic mechanics. The non-interaction theorem is proved when a Poincar-invariant Hamiltonian formulation with canonical position coordinates is required.

El olvido de los derechos del hombre (G. Agamben, R. Esposito)

La paradoja más lacerante de nuestros días es la creciente distancia entre la Declaración de los Derechos del Hombre de 1948 y su escasa implantación en la realidad cotidiana. Los derechos del hombre sólo son posibles teniendo como horizonte la Humanidad, no los Estados-nación. Los apátridas, los refugiados, los inmigrantes son el escándalo y la denuncia de esa distancia entre "derechos del hombre" y "derechos del ciudadano". Cualquier razón -cultural, política, económica- nos sirve para demonizar al "otro", al que no es como nosotros.